Transient elastography (FibroScan&reg;) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

doi:10.3748/wjg.v22.i32.7236

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 32

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (17826)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-5) series.

Item

Count

PDF

1948

WORD

544

HTML

11720

Tables (1-5)

287

Sum=14499

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

356

Download

403

Sum=759

Publishing Process of This Article

Item

Count

Browse

1121

Download

1447

Sum=2568

Aug 28, 2016 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (189)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Aug 28, 2016; 22(32): 7236-7251
Published online Aug 28, 2016. doi: 10.3748/wjg.v22.i32.7236

Table 2 Advantages of transient elastography with controlled attenuation parameter

Most widely used and validated non-invasive technique

High range of values

Well defined quality criteria

Good reproducibility

Detects liver stiffness and steatosis from the same region of interest

Excellent for the exclusion of cirrhosis

Prognostic value in cirrhosis

User-friendly

Short duration, painless

Applicable as a screening method in large populations

Citation: Mikolasevic I, Orlic L, Franjic N, Hauser G, Stimac D, Milic S. Transient elastography (FibroScan^®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? World J Gastroenterol 2016; 22(32): 7236-7251
URL: https://www.wjgnet.com/1007-9327/full/v22/i32/7236.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i32.7236